Total Payments
$11,496
2024 Payments
$4,631
Companies
19
Transactions
150
Medicare Patients
1,115
Medicare Billing
$290,032
Payment Breakdown by Category
Consulting$9,375 (81.5%)
Food & Beverage$2,107 (18.3%)
Education$14.63 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,375 | 6 | 81.5% |
| Food and Beverage | $2,107 | 143 | 18.3% |
| Education | $14.63 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Theragenics Corporation | $9,652 | 9 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $400.40 | 36 | $0 (2020) |
| Astellas Pharma US Inc | $335.13 | 22 | $0 (2020) |
| Bayer HealthCare Pharmaceuticals Inc. | $233.87 | 14 | $0 (2020) |
| PFIZER INC. | $226.75 | 26 | $0 (2020) |
| Janssen Biotech, Inc. | $100.91 | 8 | $0 (2019) |
| Dendreon Pharmaceuticals LLC | $89.83 | 7 | $0 (2020) |
| Cumberland Pharmaceuticals, Inc. | $78.52 | 6 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $72.63 | 4 | $0 (2019) |
| TOLMAR Pharmaceuticals, Inc. | $54.56 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,631 | 6 | Theragenics Corporation ($4,631) |
| 2022 | $4,901 | 2 | Theragenics Corporation ($4,901) |
| 2020 | $133.38 | 9 | Astellas Pharma US Inc ($36.13) |
| 2019 | $779.83 | 48 | Ferring Pharmaceuticals Inc. ($161.26) |
| 2018 | $559.89 | 50 | PFIZER INC. ($150.74) |
| 2017 | $490.35 | 35 | Ferring Pharmaceuticals Inc. ($119.57) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Theragenics Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/08/2024 | Theragenics Corporation | — | Food and Beverage | Cash or cash equivalent | $131.25 | General |
| 06/20/2024 | Theragenics Corporation | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 05/01/2024 | Theragenics Corporation | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 04/01/2024 | Theragenics Corporation | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 01/18/2024 | Theragenics Corporation | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 12/07/2022 | Theragenics Corporation | — | Consulting Fee | Cash or cash equivalent | $4,875.00 | General |
| 07/14/2022 | Theragenics Corporation | — | Food and Beverage | Cash or cash equivalent | $26.47 | General |
| 03/03/2020 | Boston Scientific Corporation | GENERAL - ONCOLOGY (Device) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: GENERAL | ||||||
| 02/27/2020 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: UROLOGY | ||||||
| 02/17/2020 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ONCOLOGY | ||||||
| 02/09/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2020 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: UROLOGY | ||||||
| 02/03/2020 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Prostate Cancer | ||||||
| 01/20/2020 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Oncology | ||||||
| 01/13/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2020 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/24/2019 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $1.51 | General |
| Category: UROLOGY | ||||||
| 12/23/2019 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: UROLOGY | ||||||
| 12/13/2019 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2019 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Prostate Cancer | ||||||
| 12/11/2019 | Sun Pharmaceutical Industries Inc. | ODOMZO (Drug), YONSA | Food and Beverage | Cash or cash equivalent | $15.51 | General |
| Category: Oncology | ||||||
| 12/09/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2019 | Ferring Pharmaceuticals Inc. | FIRMAGON (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: UROLOGY | ||||||
| 11/26/2019 | Boston Scientific Corporation | GENERAL ONCOLOGY (Device) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: GENERAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 28 | 1,115 | 3,861 | $1.0M | $290,032 |
Total Patients
1,115
Total Services
3,861
Medicare Billing
$290,032
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6017 | Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment | Facility | 2020 | 39 | 1,065 | $239,625 | $87,678 | 36.6% |
| 77427 | Radiation treatment management, 5 treatments | Facility | 2020 | 61 | 427 | $192,150 | $64,050 | 33.3% |
| 77014 | Ct scan guidance for insertion of radiation therapy fields | Facility | 2020 | 61 | 845 | $114,075 | $28,577 | 25.1% |
| 77301 | Management of modulation radiotherapy planning | Facility | 2020 | 48 | 48 | $52,800 | $15,700 | 29.7% |
| 77300 | Calculation of radiation therapy dose | Facility | 2020 | 59 | 524 | $157,200 | $13,371 | 8.5% |
| 77338 | Design and construction of device for radiation therapy | Facility | 2020 | 52 | 52 | $22,828 | $9,082 | 39.8% |
| 55706 | Needle stereotactic and image-guided biopsy of prostate gland | Facility | 2020 | 30 | 30 | $25,950 | $8,074 | 31.1% |
| 77263 | Management of radiation therapy, complex | Facility | 2020 | 49 | 55 | $11,290 | $6,854 | 60.7% |
| 77778 | Application of radiation source, complex | Facility | 2020 | 17 | 17 | $23,375 | $6,143 | 26.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 106 | 111 | $14,430 | $5,934 | 41.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 57 | 66 | $12,144 | $5,136 | 42.3% |
| 55700 | Biopsy of prostate gland | Facility | 2020 | 46 | 50 | $13,295 | $5,115 | 38.5% |
| 55874 | Injection of biodegradable material next to prostate | Facility | 2020 | 43 | 43 | $18,877 | $5,113 | 27.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 43 | 43 | $8,471 | $3,779 | 44.6% |
| 77318 | Radiation therapy plan | Facility | 2020 | 17 | 30 | $9,360 | $3,587 | 38.3% |
| 77295 | Management of radiation therapy, 3d | Facility | 2020 | 20 | 20 | $12,000 | $3,514 | 29.3% |
| 77334 | Radiation treatment devices, design and construction, complex | Facility | 2020 | 56 | 72 | $28,800 | $3,243 | 11.3% |
| 77470 | Special radiation treatment procedure | Facility | 2020 | 36 | 37 | $12,210 | $3,130 | 25.6% |
| 77290 | Management of radiation therapy, simulation, complex | Facility | 2020 | 28 | 47 | $9,400 | $2,875 | 30.6% |
| 76872 | Ultrasound of rectum | Facility | 2020 | 74 | 85 | $8,500 | $2,223 | 26.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 17 | 17 | $4,743 | $2,136 | 45.0% |
| 55876 | Insertion of radiation therapy devices in prostate gland for radiation therapy guidance | Facility | 2020 | 30 | 30 | $9,330 | $1,037 | 11.1% |
| 76965 | Ultrasonic guidance for administration of radiation therapy | Facility | 2020 | 17 | 17 | $3,740 | $905.72 | 24.2% |
| 77280 | Management of radiation therapy simulation, simple | Facility | 2020 | 15 | 28 | $2,072 | $808.19 | 39.0% |
| 76873 | Ultrasound of prostate | Facility | 2020 | 14 | 14 | $3,500 | $796.27 | 22.8% |
About Dr. Gregory Merrick, MD
Dr. Gregory Merrick, MD is a Radiation Oncology healthcare provider based in Wheeling, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992774673.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Merrick, MD has received a total of $11,496 in payments from pharmaceutical and medical device companies, with $4,631 received in 2024. These payments were reported across 150 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($9,375).
As a Medicare-enrolled provider, Merrick has provided services to 1,115 Medicare beneficiaries, totaling 3,861 services with total Medicare billing of $290,032. Data is available for 1 year (2020–2020), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Wheeling, WV
- Active Since 03/16/2006
- Last Updated 08/14/2012
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1992774673
Products in Payments
- XTANDI (Drug) $551.60
- FIRMAGON (Drug) $400.40
- Xofigo (Drug) $180.58
- PROVENGE (Drug) $89.83
- Ethyol (Drug) $78.52
- KEYTRUDA (Biological) $72.63
- ZYTIGA (Drug) $62.34
- ELIGARD (Drug) $54.56
- Nubeqa (Drug) $53.29
- Xtandi (Drug) $40.94
- GENERAL ONCOLOGY (Device) $40.76
- Erleada (Drug) $38.57
- THYROGEN (Drug) $32.00
- Prolia (Biological) $29.34
- SUBSYS (Drug) $20.44
- XGEVA (Biological) $15.73
- ODOMZO (Drug) $15.51
- GENERAL - ONCOLOGY (Device) $12.35
- Lupron (Drug) $12.26
- IMFINZI (Drug) $11.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.